Company / CapEx per Share
Emergent BioSolutions Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.26
FY2025
5-year range
$0.26 / $4.37
FY2021-FY2025
Trend
-37.2%
vs FY2024
Sector context
#40 of 192
Health Care
What the data says
Emergent BioSolutions Inc.'s capex per share of $0.26 is higher than 79% of companies in the Health Care sector (FY2025). CapEx per Share has declined for 4 consecutive years, from $4.37 in FY2021 to $0.26 in FY2025.
Based on SEC 10-K filings.
0.26 in FY2025 with a 5-year CAGR of -37.3%. Top quartile in the Health Care sector.
Declined from $0.99 to $0.26 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -51.0%
- 5-Year CAGR
- -37.3%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 192This company $0.26 Sector average $3.54
▼
-92.5% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s capex per share has declined for 4 consecutive years.
- In FY2025, capex per share decreased 37.2% year-over-year.
- Ranks #40 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.26 | -37.2% |
| FY2024 | $0.42 | -57.3% |
| FY2023 | $0.99 | -56.2% |
| FY2022 | $2.26 | -48.3% |
| FY2021 | $4.37 | +60.2% |
| FY2020 | $2.73 | +62.3% |
| FY2019 | $1.68 | +9.0% |
| FY2018 | $1.54 | +14.2% |
| FY2017 | $1.35 | -30.2% |
| FY2016 | $1.93 | +62.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026